Peter Miller to Oxymorphone
This is a "connection" page, showing publications Peter Miller has written about Oxymorphone.
Connection Strength
1.825
-
Bonnecaze AK, Wilson MW, Dharod A, Fletcher A, Miller PJ. Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging. Nephrology (Carlton). 2018 Oct; 23(10):921-926.
Score: 0.641
-
Wilson MW, Bonnecaze AK, Dharod A, Miller PJ. Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone. South Med J. 2017 03; 110(3):217-222.
Score: 0.574
-
Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7.
Score: 0.470
-
Hunt R, Yalamanoglu A, Tumlin J, Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C. A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER. Blood. 2017 02 16; 129(7):896-905.
Score: 0.141